Torii Pharmaceutical (TRXPF) 20.3500 $TRXPF ALK
Post# of 273249
Posted On: 09/27/2016 3:28:50 PM
Torii Pharmaceutical (TRXPF) 20.3500 $TRXPF
ALK's partner, Torii, submits registration application for the cedar SLIT-tablet in Japan
GlobeNewswire - Fri Dec 25, 3:10AM CST
ALK ( ALKB
C/ OMX: ALK B / AKABY / AKBLF) today announced that its partner, Torii, has submitted a New Drug Application in Japan for the Japanese cedar pollen sublingual allergy immunotherapy tablet for the indication of allergic rhinitis (hay fever).
MRK: 62.59 (+0.44)
ALK's partner, Torii, submits registration application for the house dust mite SLIT-tablet in Japan
GlobeNewswire - Mon Jan 26, 2:02AM CST
ALK (ALKBC / OMX: ALK B / AKABY / AKBLF) today announced that its partner, Torii, has submitted a New Drug Application in Japan for ALK's house dust mite sublingual allergy immunotherapy tablet for the indication of allergic rhinitis.
ALK's partner, Torii, submits registration application for the cedar SLIT-tablet in Japan
GlobeNewswire - Fri Dec 25, 3:10AM CST
ALK ( ALKB
C/ OMX: ALK B / AKABY / AKBLF) today announced that its partner, Torii, has submitted a New Drug Application in Japan for the Japanese cedar pollen sublingual allergy immunotherapy tablet for the indication of allergic rhinitis (hay fever). MRK: 62.59 (+0.44)
ALK's partner, Torii, submits registration application for the house dust mite SLIT-tablet in Japan
GlobeNewswire - Mon Jan 26, 2:02AM CST
ALK (ALKB
C / OMX: ALK B / AKABY / AKBLF) today announced that its partner, Torii, has submitted a New Drug Application in Japan for ALK's house dust mite sublingual allergy immunotherapy tablet for the indication of allergic rhinitis. 
(0)
(0)Scroll down for more posts ▼